Odds ratio (OR) for educational categories relative to tertiary education, and Relative Index of Inequality (RII)
| . | Men . | Women . | ||||
|---|---|---|---|---|---|---|
| . | 1971–79 . | 1980–89 . | 1990–2002 . | 1971–79 . | 1980–89 . | 1990–2002 . |
| . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . |
| Lung and larynx | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.59 (1.37–1.84) | 1.52 (1.35–1.79) | 1.59 (1.47–1.74) | 1.77 (1.16–2.70) | 1.51 (1.14–2.00 | 1.77 (1.50–2.13) |
| Basic | 1.37 (1.21–1.54) | 1.66 (1.51–1.82) | 2.02 (1.89–2.17) | 1.12 (0.82–1.54) | 1.29 (1.05–1.57) | 2.17 (1.92–2.45) |
| RII | 1.17 (1.00–1.37) | 1.85 (1.63–2.10) | 2.78 (2.52–3.07) | 0.76 (0.49–1.19) | 1.18 (0.88–1.59) | 3.18 (2.63–3.83) |
| Colorectal | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.04 (0.86–1.26) | 1.16 (1.00–1.33) | 1.16 (1.05–1.28) | 1.47 (1.10–1.97) | 0.83 (0.65–1.07) | 1.19 (1.01–1.41) |
| Basic | 0.92 (0.80–1.05) | 1.00 (0.89–1.12) | 1.07 (0.99–1.16) | 1.13 (0.92–1.39) | 1.03 (0.88–1.20) | 1.17 (1.05–1.31) |
| RII | 0.81 (0.66–1.00) | 0.89 (0.76–1.04) | 1.04 (0.92–1.18) | 0.93 (0.69–1.26) | 1.19 (0.93–1.53) | 1.24 (1.03–1.48) |
| Stomach | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.18 (0.96–1.45) | 1.36 (1.11–1.67) | 1.15 (0.97–1.38) | 0.67 (0.41–1.09) | 0.73 (0.48–1.11) | 1.03 (0.71–1.48) |
| Basic | 1.46 (1.25–1.71) | 1.73 (1.47–2.03) | 1.55 (1.36–1.77) | 1.29 (0.98–1.69) | 1.11 (0.87–1.42) | 1.49 (1.19–1.86) |
| RII | 1.82 (1.46–2.27) | 2.23 (1.78–2.79) | 2.14 (1.74–2.62) | 2.13 (1.36–3.35) | 1.50 (1.00–2.23) | 2.21 (1.52–3.22) |
| Melanoma | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.01 (0.65–1.56) | 0.94 (0.69–1.29) | 1.06 (0.87–1.29) | 2.29 (1.14–4.62) | 1.09 (0.57–2.07) | 0.81 (0.52–1.25) |
| Basic | 0.83 (0.59–1.15) | 0.81 (0.64–1.03) | 0.82 (0.70–0.97) | 0.85 (0.48–1.48) | 1.01 (0.66–1.53) | 0.94 (0.73–1.20) |
| RII | 0.68 (0.42–1.12) | 0.69 (0.49–1.01) | 0.67 (0.52–0.86) | 0.32 (0.15–0.68) | 0.96 (0.49–1.87) | 0.96 (0.62–1.48) |
| Prostate | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 1.11 (0.90–1.37) | 1.06 (0.90–1.24) | 0.92 (0.81–1.03) | |||
| Basic | 0.95 (0.81–1.12) | 0.94 (0.83–1.06) | 0.98 (0.90–1.07) | |||
| RII | 0.83 (0.66–1.05) | 0.84 (0.70–1.01) | 1.01 (0.87–1.16) | |||
| Breast | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 0.98 (0.78–1.23) | 1.02 (0.87–1.23) | 0.98 (0.86–1.12) | |||
| Basic | 0.90 (0.78–1.04) | 0.87 (0.77–0.98) | 0.88 (0.81–0.95) | |||
| RII | 0.82 (0.65–1.04) | 0.75 (0.62–0.91) | 0.77 (0.67–0.89) | |||
| Cervix uteri | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 1.48 (0.85–2.58) | 2.65 (1.58–4.45) | 1.27 (0.85–1.89) | |||
| Basic | 2.03 (1.36–3.01) | 2.87 (1.91–4.30) | 1.98 (1.55–2.54) | |||
| RII | 2.92 (1.65–5.19) | 3.38 (1.99–5.75) | 3.39 (2.25–5.11) | |||
| . | Men . | Women . | ||||
|---|---|---|---|---|---|---|
| . | 1971–79 . | 1980–89 . | 1990–2002 . | 1971–79 . | 1980–89 . | 1990–2002 . |
| . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . |
| Lung and larynx | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.59 (1.37–1.84) | 1.52 (1.35–1.79) | 1.59 (1.47–1.74) | 1.77 (1.16–2.70) | 1.51 (1.14–2.00 | 1.77 (1.50–2.13) |
| Basic | 1.37 (1.21–1.54) | 1.66 (1.51–1.82) | 2.02 (1.89–2.17) | 1.12 (0.82–1.54) | 1.29 (1.05–1.57) | 2.17 (1.92–2.45) |
| RII | 1.17 (1.00–1.37) | 1.85 (1.63–2.10) | 2.78 (2.52–3.07) | 0.76 (0.49–1.19) | 1.18 (0.88–1.59) | 3.18 (2.63–3.83) |
| Colorectal | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.04 (0.86–1.26) | 1.16 (1.00–1.33) | 1.16 (1.05–1.28) | 1.47 (1.10–1.97) | 0.83 (0.65–1.07) | 1.19 (1.01–1.41) |
| Basic | 0.92 (0.80–1.05) | 1.00 (0.89–1.12) | 1.07 (0.99–1.16) | 1.13 (0.92–1.39) | 1.03 (0.88–1.20) | 1.17 (1.05–1.31) |
| RII | 0.81 (0.66–1.00) | 0.89 (0.76–1.04) | 1.04 (0.92–1.18) | 0.93 (0.69–1.26) | 1.19 (0.93–1.53) | 1.24 (1.03–1.48) |
| Stomach | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.18 (0.96–1.45) | 1.36 (1.11–1.67) | 1.15 (0.97–1.38) | 0.67 (0.41–1.09) | 0.73 (0.48–1.11) | 1.03 (0.71–1.48) |
| Basic | 1.46 (1.25–1.71) | 1.73 (1.47–2.03) | 1.55 (1.36–1.77) | 1.29 (0.98–1.69) | 1.11 (0.87–1.42) | 1.49 (1.19–1.86) |
| RII | 1.82 (1.46–2.27) | 2.23 (1.78–2.79) | 2.14 (1.74–2.62) | 2.13 (1.36–3.35) | 1.50 (1.00–2.23) | 2.21 (1.52–3.22) |
| Melanoma | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.01 (0.65–1.56) | 0.94 (0.69–1.29) | 1.06 (0.87–1.29) | 2.29 (1.14–4.62) | 1.09 (0.57–2.07) | 0.81 (0.52–1.25) |
| Basic | 0.83 (0.59–1.15) | 0.81 (0.64–1.03) | 0.82 (0.70–0.97) | 0.85 (0.48–1.48) | 1.01 (0.66–1.53) | 0.94 (0.73–1.20) |
| RII | 0.68 (0.42–1.12) | 0.69 (0.49–1.01) | 0.67 (0.52–0.86) | 0.32 (0.15–0.68) | 0.96 (0.49–1.87) | 0.96 (0.62–1.48) |
| Prostate | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 1.11 (0.90–1.37) | 1.06 (0.90–1.24) | 0.92 (0.81–1.03) | |||
| Basic | 0.95 (0.81–1.12) | 0.94 (0.83–1.06) | 0.98 (0.90–1.07) | |||
| RII | 0.83 (0.66–1.05) | 0.84 (0.70–1.01) | 1.01 (0.87–1.16) | |||
| Breast | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 0.98 (0.78–1.23) | 1.02 (0.87–1.23) | 0.98 (0.86–1.12) | |||
| Basic | 0.90 (0.78–1.04) | 0.87 (0.77–0.98) | 0.88 (0.81–0.95) | |||
| RII | 0.82 (0.65–1.04) | 0.75 (0.62–0.91) | 0.77 (0.67–0.89) | |||
| Cervix uteri | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 1.48 (0.85–2.58) | 2.65 (1.58–4.45) | 1.27 (0.85–1.89) | |||
| Basic | 2.03 (1.36–3.01) | 2.87 (1.91–4.30) | 1.98 (1.55–2.54) | |||
| RII | 2.92 (1.65–5.19) | 3.38 (1.99–5.75) | 3.39 (2.25–5.11) | |||
Odds ratio (OR) for educational categories relative to tertiary education, and Relative Index of Inequality (RII)
| . | Men . | Women . | ||||
|---|---|---|---|---|---|---|
| . | 1971–79 . | 1980–89 . | 1990–2002 . | 1971–79 . | 1980–89 . | 1990–2002 . |
| . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . |
| Lung and larynx | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.59 (1.37–1.84) | 1.52 (1.35–1.79) | 1.59 (1.47–1.74) | 1.77 (1.16–2.70) | 1.51 (1.14–2.00 | 1.77 (1.50–2.13) |
| Basic | 1.37 (1.21–1.54) | 1.66 (1.51–1.82) | 2.02 (1.89–2.17) | 1.12 (0.82–1.54) | 1.29 (1.05–1.57) | 2.17 (1.92–2.45) |
| RII | 1.17 (1.00–1.37) | 1.85 (1.63–2.10) | 2.78 (2.52–3.07) | 0.76 (0.49–1.19) | 1.18 (0.88–1.59) | 3.18 (2.63–3.83) |
| Colorectal | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.04 (0.86–1.26) | 1.16 (1.00–1.33) | 1.16 (1.05–1.28) | 1.47 (1.10–1.97) | 0.83 (0.65–1.07) | 1.19 (1.01–1.41) |
| Basic | 0.92 (0.80–1.05) | 1.00 (0.89–1.12) | 1.07 (0.99–1.16) | 1.13 (0.92–1.39) | 1.03 (0.88–1.20) | 1.17 (1.05–1.31) |
| RII | 0.81 (0.66–1.00) | 0.89 (0.76–1.04) | 1.04 (0.92–1.18) | 0.93 (0.69–1.26) | 1.19 (0.93–1.53) | 1.24 (1.03–1.48) |
| Stomach | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.18 (0.96–1.45) | 1.36 (1.11–1.67) | 1.15 (0.97–1.38) | 0.67 (0.41–1.09) | 0.73 (0.48–1.11) | 1.03 (0.71–1.48) |
| Basic | 1.46 (1.25–1.71) | 1.73 (1.47–2.03) | 1.55 (1.36–1.77) | 1.29 (0.98–1.69) | 1.11 (0.87–1.42) | 1.49 (1.19–1.86) |
| RII | 1.82 (1.46–2.27) | 2.23 (1.78–2.79) | 2.14 (1.74–2.62) | 2.13 (1.36–3.35) | 1.50 (1.00–2.23) | 2.21 (1.52–3.22) |
| Melanoma | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.01 (0.65–1.56) | 0.94 (0.69–1.29) | 1.06 (0.87–1.29) | 2.29 (1.14–4.62) | 1.09 (0.57–2.07) | 0.81 (0.52–1.25) |
| Basic | 0.83 (0.59–1.15) | 0.81 (0.64–1.03) | 0.82 (0.70–0.97) | 0.85 (0.48–1.48) | 1.01 (0.66–1.53) | 0.94 (0.73–1.20) |
| RII | 0.68 (0.42–1.12) | 0.69 (0.49–1.01) | 0.67 (0.52–0.86) | 0.32 (0.15–0.68) | 0.96 (0.49–1.87) | 0.96 (0.62–1.48) |
| Prostate | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 1.11 (0.90–1.37) | 1.06 (0.90–1.24) | 0.92 (0.81–1.03) | |||
| Basic | 0.95 (0.81–1.12) | 0.94 (0.83–1.06) | 0.98 (0.90–1.07) | |||
| RII | 0.83 (0.66–1.05) | 0.84 (0.70–1.01) | 1.01 (0.87–1.16) | |||
| Breast | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 0.98 (0.78–1.23) | 1.02 (0.87–1.23) | 0.98 (0.86–1.12) | |||
| Basic | 0.90 (0.78–1.04) | 0.87 (0.77–0.98) | 0.88 (0.81–0.95) | |||
| RII | 0.82 (0.65–1.04) | 0.75 (0.62–0.91) | 0.77 (0.67–0.89) | |||
| Cervix uteri | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 1.48 (0.85–2.58) | 2.65 (1.58–4.45) | 1.27 (0.85–1.89) | |||
| Basic | 2.03 (1.36–3.01) | 2.87 (1.91–4.30) | 1.98 (1.55–2.54) | |||
| RII | 2.92 (1.65–5.19) | 3.38 (1.99–5.75) | 3.39 (2.25–5.11) | |||
| . | Men . | Women . | ||||
|---|---|---|---|---|---|---|
| . | 1971–79 . | 1980–89 . | 1990–2002 . | 1971–79 . | 1980–89 . | 1990–2002 . |
| . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . | OR/RII (95%CI) . |
| Lung and larynx | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.59 (1.37–1.84) | 1.52 (1.35–1.79) | 1.59 (1.47–1.74) | 1.77 (1.16–2.70) | 1.51 (1.14–2.00 | 1.77 (1.50–2.13) |
| Basic | 1.37 (1.21–1.54) | 1.66 (1.51–1.82) | 2.02 (1.89–2.17) | 1.12 (0.82–1.54) | 1.29 (1.05–1.57) | 2.17 (1.92–2.45) |
| RII | 1.17 (1.00–1.37) | 1.85 (1.63–2.10) | 2.78 (2.52–3.07) | 0.76 (0.49–1.19) | 1.18 (0.88–1.59) | 3.18 (2.63–3.83) |
| Colorectal | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.04 (0.86–1.26) | 1.16 (1.00–1.33) | 1.16 (1.05–1.28) | 1.47 (1.10–1.97) | 0.83 (0.65–1.07) | 1.19 (1.01–1.41) |
| Basic | 0.92 (0.80–1.05) | 1.00 (0.89–1.12) | 1.07 (0.99–1.16) | 1.13 (0.92–1.39) | 1.03 (0.88–1.20) | 1.17 (1.05–1.31) |
| RII | 0.81 (0.66–1.00) | 0.89 (0.76–1.04) | 1.04 (0.92–1.18) | 0.93 (0.69–1.26) | 1.19 (0.93–1.53) | 1.24 (1.03–1.48) |
| Stomach | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.18 (0.96–1.45) | 1.36 (1.11–1.67) | 1.15 (0.97–1.38) | 0.67 (0.41–1.09) | 0.73 (0.48–1.11) | 1.03 (0.71–1.48) |
| Basic | 1.46 (1.25–1.71) | 1.73 (1.47–2.03) | 1.55 (1.36–1.77) | 1.29 (0.98–1.69) | 1.11 (0.87–1.42) | 1.49 (1.19–1.86) |
| RII | 1.82 (1.46–2.27) | 2.23 (1.78–2.79) | 2.14 (1.74–2.62) | 2.13 (1.36–3.35) | 1.50 (1.00–2.23) | 2.21 (1.52–3.22) |
| Melanoma | ||||||
| Tertiary | 1 | 1 | 1 | 1 | 1 | 1 |
| Secondary | 1.01 (0.65–1.56) | 0.94 (0.69–1.29) | 1.06 (0.87–1.29) | 2.29 (1.14–4.62) | 1.09 (0.57–2.07) | 0.81 (0.52–1.25) |
| Basic | 0.83 (0.59–1.15) | 0.81 (0.64–1.03) | 0.82 (0.70–0.97) | 0.85 (0.48–1.48) | 1.01 (0.66–1.53) | 0.94 (0.73–1.20) |
| RII | 0.68 (0.42–1.12) | 0.69 (0.49–1.01) | 0.67 (0.52–0.86) | 0.32 (0.15–0.68) | 0.96 (0.49–1.87) | 0.96 (0.62–1.48) |
| Prostate | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 1.11 (0.90–1.37) | 1.06 (0.90–1.24) | 0.92 (0.81–1.03) | |||
| Basic | 0.95 (0.81–1.12) | 0.94 (0.83–1.06) | 0.98 (0.90–1.07) | |||
| RII | 0.83 (0.66–1.05) | 0.84 (0.70–1.01) | 1.01 (0.87–1.16) | |||
| Breast | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 0.98 (0.78–1.23) | 1.02 (0.87–1.23) | 0.98 (0.86–1.12) | |||
| Basic | 0.90 (0.78–1.04) | 0.87 (0.77–0.98) | 0.88 (0.81–0.95) | |||
| RII | 0.82 (0.65–1.04) | 0.75 (0.62–0.91) | 0.77 (0.67–0.89) | |||
| Cervix uteri | ||||||
| Tertiary | 1 | 1 | 1 | |||
| Secondary | 1.48 (0.85–2.58) | 2.65 (1.58–4.45) | 1.27 (0.85–1.89) | |||
| Basic | 2.03 (1.36–3.01) | 2.87 (1.91–4.30) | 1.98 (1.55–2.54) | |||
| RII | 2.92 (1.65–5.19) | 3.38 (1.99–5.75) | 3.39 (2.25–5.11) | |||
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
